Bioceres CEO discloses share and option holdings

Bioceres Crop Solutions Corp. CEO Federico Trucco filed an initial ownership report showing his existing stake in the company.

Rhea-AI Filing Summary

Bioceres Crop Solutions Corp. CEO Federico Trucco filed an initial ownership report showing his existing stake in the company. He directly holds 356,000 Ordinary Shares. He also holds stock options over 1,300,000 Ordinary Shares, including 1,000,000 options at an exercise price of $10.47 per share expiring in 2030 and 300,000 options at $4.55 per share expiring in 2029. This filing records current holdings and does not report any new purchases or sales.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Trucco Federico

Role CEO

Type	Security	Shares	Price	Value
holding	Stock Options representing a right to buy	--	--	--
holding	Stock Options representing a right to buy	--	--	--
holding	Stock Options representing a right to buy	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Stock Options representing a right to buy — 1,300,000 contracts (Direct); Ordinary Shares — 356,000 shares (Direct)

Key Figures

Direct Ordinary Shares: 356,000 shares Options underlying shares (total): 1,300,000 shares Option exercise price: $10.47/share +3 more

6 metrics

Direct Ordinary Shares 356,000 shares Directly owned by CEO Federico Trucco

Options underlying shares (total) 1,300,000 shares Underlying Ordinary Shares from stock options

Option exercise price $10.47/share Stock options expiring June 30, 2030

Option exercise price $4.55/share Stock options expiring October 31, 2029

Options expiring 2030 1,000,000 underlying shares Stock options with $10.47 exercise price

Options expiring 2029 300,000 underlying shares Stock options with $4.55 exercise price

Key Terms

Ordinary Shares, Stock Options representing a right to buy, exercise price, expiration date

4 terms

Ordinary Shares financial

"He directly holds 356,000 Ordinary Shares."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Stock Options representing a right to buy financial

"Stock Options representing a right to buy … underlying Ordinary Shares."

exercise price financial

"including 1,000,000 options at an exercise price of $10.47 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"options at $10.47 per share expiring in 2030 and $4.55 expiring in 2029"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Bioceres (BIOX) CEO Federico Trucco report in this Form 3?

Federico Trucco reports his existing ownership in Bioceres, including 356,000 Ordinary Shares and stock options over 1,300,000 Ordinary Shares. The filing is an initial ownership statement and does not disclose any new share purchases or sales.

How many Bioceres (BIOX) Ordinary Shares does the CEO directly own?

The CEO directly owns 356,000 Ordinary Shares of Bioceres Crop Solutions Corp. This figure reflects his current direct equity position as reported in the Form 3 initial beneficial ownership statement filed with the SEC.

What stock options over Bioceres (BIOX) shares does the CEO hold?

The CEO holds stock options over 1,300,000 Ordinary Shares of Bioceres, including 1,000,000 options with a $10.47 exercise price expiring in 2030 and 300,000 options with a $4.55 exercise price expiring in 2029.

Does this Bioceres (BIOX) Form 3 show the CEO buying or selling shares?

The Form 3 does not show the CEO buying or selling shares. It lists existing holdings: direct ownership of 356,000 Ordinary Shares and stock options over 1,300,000 Ordinary Shares, without any reported purchase or sale transactions.

What is the significance of a Form 3 for Bioceres (BIOX) investors?

A Form 3 shows an insider’s initial beneficial ownership when they become an officer, director, or large shareholder. For Bioceres, it establishes the CEO’s baseline holdings in Ordinary Shares and stock options, providing transparency on his equity stake in the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Trucco Federico

(Last) (First) (Middle)

H. IRIGOYEN 1655

(Street)

SAN JORGE SANTA FE CP 2453

(City) (State) (Zip)

ARGENTINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/13/2019

3. Issuer Name and Ticker or Trading Symbol
Bioceres Crop Solutions Corp. [ BIOX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	356,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options representing a right to buy	04/24/2019	10/31/2029	Ordinary Shares	300,000	$4.55	D
Stock Options representing a right to buy	06/30/2025	06/30/2030	Ordinary Shares	500,000	$10.47	D
Stock Options representing a right to buy	06/30/2025	06/30/2030	Ordinary Shares	500,000	$10.47	D

Explanation of Responses:

	/s/ Federico Trucco	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)